NEW ACADEMIC PROGRAM – IMPLEMENTATION REQUEST
I. PROGRAM NAME, DESCRIPTION AND CIP CODE A. PROPOSED PROGRAM NAME AND DEGREE(S) TO BE OFFERED – for PhD programs indicate whether a terminal Master’s degree will also be offered. “Molecular Medicine” This is a proposal for a PhD program that would also offer a terminal Master’s degree. B. CIP CODE – go to the National Statistics for Education web site (http://nces.ed.gov/ipeds/cipcode/browse.aspx?y=55) to select an appropriate CIP Code or contact Pam Coonan (621‐0950) [email protected] for assistance. Cellular and Molecular Medicine has CIP code 26.1401 (Molecular Medicine) Immunobiology has CIP code 26.0599 (Microbiological Sciences and Immunology, Other) For this new program, we propose Molecular Medicine (26.1401) C. DEPARTMENT/UNIT AND COLLEGE – indicate the managing dept/unit and college for multi‐ interdisciplinary programs with multiple participating units/colleges. This program would be co‐administered by the Immunobiology (IMB) and Cellular and Molecular Medicine (CMM) Departments in the College of Medicine – Tucson (COM‐ Tucson). II. PURPOSE AND NATURE OF PROGRAM–Please describe the purpose and nature of your program and explain the ways in which it is similar to and different from similar programs at two public peer institutions. Please use the attached comparison chart to assist you. This program represents a merger between existing PhD programs – Immunobiology (IMB) and Cellular and Molecular Medicine (CMM). The merger of the two programs would build cohesiveness among the students while facilitating scientific interactionbetween the faculties of the respective departments. The two programs have similar goals, structures, and degree requirements. The merger into a new program would reduce redundancy and overlap in COM graduate programs and help each program better meet ABOR metrics for successful graduate programs. Each program admits ≈3 students per year, and this new program would therefore approximately double the number of students than either program alone (see table below). Once the program is established, it would supplant the individual IMB and CMM PhD programs; they would no longer admit students. Two PhD programs in Molecular Medicine at peer institutions are described below for comparative purposes – at George Washington University and University of Texas Health Sciences Center – San Antonio. George Washington University: Description: “Modern biomedical research uses a variety of approaches to achieve a better understanding of human health and disease. These include systems analysis of physiological studies, microscopic anatomical techniques and powerful methods that expand our knowledge at a molecular level. In the molecular and cellular oncology track, the disease of cancer is a unifying research focus, ranging from molecular signaling underlying carcinogenesis to cancer genomics for improving detection, diagnosis and treatment. For the neuroscience track, research interests span neurotransmitter signaling to neurodevelopmental disorders to developmental neurobiology. The pharmacology and physiology track centers on biological systems, including the interaction of molecules (drugs), function integration of organ systems and how cells regulate ionic metabolic fluxes under normal and pathophysiological states.” Faculty size: 38 http://www.gwu.edu/graduate‐programs/biomedical‐sciences‐molecular‐medicine University of Texas Health Sciences Center – San Antonio: Description: “The Graduate Program in Molecular Medicine was established in 1993 as a forward‐looking academic program designed to train students at the interface of basic and clinical sciences. Its inception marked the first such program in the State of Texas, and was rooted in the firm belief that rigorous training of scientists in the
genetic and biochemical basis of human disease would provide an effective means to translate rapid advances in basic research into practical health benefits for the 21st century public. Accordingly, the Program in Molecular Medicine offers a research‐ oriented, interdisciplinary program of study in the following areas as they relate to the fundamental understanding of cancer biology and its prevention: signal transduction and control of gene expression, cell cycle and checkpoint controls, DNA damage repair and mechanisms of genomic instability, regulated protein degradation, and animal models of aging and cancer. The curriculum provides a program for those seeking the Master of Science and Doctor of Philosophy degrees.” Faculty size: 62 http://molecularmedicine.uthscsa.edu/Graduate.aspx University of Arizona: The proposed Molecular Medicine program shares with these peer programs the goal of training students to work at the interface of basic and translational biomedical science. As with these other programs, students will receive a solid foundation in basic biomedical sciences along with an emphasis on how these concepts integrate with human health and disease. This is made possible by the combined expertise of participating basic and translational science faculty. The Molecular Medicine Program at Arizona will be unique in its areas of emphasis. Specifically, we will combine the strengths of the CMM Program (cardiovascular disease biology, cell polarity and intracellular trafficking, cancer biology, complex disease biology and genetics, and human anatomy and histology) with those of the IMB Program (microbial and immunological/inflammatory aspects of disease). Overall, this will leverage the respective strengths of the existing programs to create an unique and rich training environment in molecular medicine for doctoral students. Faculty size: 51 (see Item VI below) III. PROGRAM REQUIREMENTS – list the program requirements, including minimum number of credit hours, required courses, and any special requirements, including subspecializations, subplans, theses, internships, etc. Use the comparison chart to explain how your requirements are similar to and different from the two programs at the two public peer institutions to which you compared your program in Section II. A. CURRENT COURSES AND EXISTING PROGRAMS ‐‐ list current courses and existing university programs which will give strengths to the proposed program. If the
courses listed belong to a department that is not a signed party to this implementation request, please obtain the department head’s permission to include the courses in the proposed program and information regarding accessibility to the course(s) for students in the proposed program. NOTE: As this represents a merger of two existing programs, all of the proposed courses were already requirements or electives under the two existing programs. Thus, no substantial changes to existing courses from other units will be required as there would be negligible change in the enrollment of any courses listed under this proposal.
CORE REQUIREMENTS Credits Grading
Principles of Cell Biology (CMM/MCB 577; Fall semester) 4 A/B/C Science, Society, & Ethics (CMM/MCB 695E; Spring semester) or equivalent ethics course. 1 S/P/F Course in bioinformatics. One example is Introduction to Systems Biology (MCB 580; Fall semester), but an equivalent course in bioinformatics/computational biology may be appropriate, subject to approval by the Graduate Studies Committee 3 A/B/C Seminar Series (CMM 696A or IMB 696A; Spring and Fall) 6 (1/semester) A/B/C Student Seminar (CMM 696B or IMB 696B; Spring and Fall) 6 (1/semester) A/B/C Minimum of 4 semesters of a Colloquium Course. Each Emphasis Track has specific recommendations, given below under each Track. 4 (1/semester) A/B/C CMM or IMB 900 Research Units 6 S/P/F CMM or IMB 920 Dissertation Units 18 S/P/F Credit Subtotal: 48 EMPHASIS TRACKS (at least 6 credits, not including Colloquium Courses) Immunobiology Track ‐ Immunobiology Journal Club (IMB 595A) or equivalent Colloquium Course (Spring and Fall) 1 x 4 (counted A/B/C
‐ IMB 548 Basic Immunological Concepts (Fall) ‐ IMB 565 Principles and Molecular Mechanisms of Microbe‐ Host Interactions (Spring) Recommended electives: ‐ Medical Immunology and Microbial Pathogenesis (CMM/IMB 605; Fall) ‐ Scientific Writing (IMB 521; Fall) ‐ Evolution of Infectious Disease (ECOL 509; Fall) ‐ Nucleic Acids, Metabolism, and Signaling (BIOC 568; Spring) above) 3 3 4 2 3 4 A/B/C A/B/C A/B/C A/B/C A/B/C A/B/C Cell Biology Track ‐ Seminar in Protein Trafficking (CMM 596B) or equivalent Colloquium Course (Spring and Fall) Choose TWO of the following courses that provide a foundation in the cellular and molecular underpinnings of disease processes: ‐ Problems in Biology of Complex Diseases (CMM 595H; Spring) ‐ Human Genetic Disease Colloquium (CMM 695D; Fall) ‐ Mechanisms of Human Disease (PATH 515; Spring) ‐ Cancer Biology Survey Course (CBIO 552; Fall) ‐ Cell Systems (MCB 572A; Fall) Recommended electives: ‐ Principles of Cellular and Molecular Neurobiology (CMM 588; Fall) ‐ Scientific Writing (IMB 521; Fall) ‐ Nucleic Acids, Metabolism, and Signaling (BIOC 568; Spring) ‐ Genetics and Molecular Networks (MCB 546; Spring) 1 x 4 (counted above) 2 3 4 4 4 4 2 4 4 A/B/C A/B/C A/B/C A/B/C A/B/C A/B/C A/B/C A/B/C A/B/C A/B/C Medical Biophysics Track ‐ Medical Biophysics Colloquium (CMM 5XX) or equivalent Colloquium Course (Spring and Fall) 1 x 4 (counted A/B/C
‐ Cardiovascular Muscle Biology and Disease (PSIO/CMM 584; Spring). Note: Henk Granzier (CMM) is the Course Director. Choose ONE of the following: ‐ Fundamentals of Light Microscopy and Electronic Imaging (CMM 565A; Spring) ‐ Methods of Physical Biochemistry (BIOC 555; Fall) or equivalent ‐ Biological Structure I (BIOC 585; Spring) or equivalent Recommended electives: ‐ Problems in Biology of Complex Diseases (CMM 595H; Spring), or equivalent ‐ Biostatistics of Research (CPH 576B; Spring), or equivalent ‐ Proteins and Enzymes (BIOC 565; Fall) , or equivalent ‐ Computational Biophysics (BIOC 567; Spring) or equivalent above) 3 3 3 4 2 3 3 3 A/B/C A/B/C A/B/C A/B/C A/B/C A/B/C A/B/C A/B/C Credit Subtotal: 54 MINOR A Minor is required and there are a variety of Minors that may be appropriate. The choice of Minor will be made by the student in conjunction with the Dissertation Advisor. The Minor consists of 9 credits. The course requirements for a Minor are dictated by the respective Programs. Students may take the option of a Minor in Molecular Medicine. This Minor would be comprised of elective courses (see list above) tailored to the student’s needs, and approved by the Graduate Studies Committee in Molecular Medicine. 9 Credit Subtotal: 63 ELECTIVES To complete the required number of credits, students may take additional courses. Some suggested electives have been
listed under each Emphasis Track, but students may take other courses that meet the needs of their training plans, with permission of the Graduate Studies Committee. ESTIMATED TOTAL: 63+ ADDITIONAL PROGRAM REQUIREMENTS Comprehensive Exam. Students are required to pass a Comprehensive Exam. The exam is intended to test the breadth and the depth of the student's knowledge in his/her area of research and in related areas of science. The exam consists of two parts, a written examination and an oral examination. The written exam is in the form of an NIH‐style grant proposal. Students that fail the exam will have one opportunity to retake the exam. Dissertation. In order to earn a PhD, the student must write and defend a dissertation. This will be a scholarly work reviewing in depth the field in which the student has done his/her research, and a thorough and critical exposition of the student's research. The dissertation must be prepared according to Graduate College requirements, with input from the student's advisor and dissertation committee. The final step for a student completing the PhD is the defense of the dissertation. The student must give a formal presentation of his/her research in a one‐hour seminar that is open to the University community. This public seminar is followed by a closed defense with the dissertation committee. B. NEW COURSES NEEDED ‐‐ list any new courses which must be added to initiate the program; include a course prefix, number, title, catalog description and number of units for each of these courses. CMM 5XX Medical Biophysics Colloquium. This is a new course under development for this Program. It will be a 1‐credit colloquium course with an emphasis on the presentation and discussion of the primary scientific literature in medical biophysics. C. REQUIREMENTS FOR ACCREDITATION ‐‐ describe the requirements for accreditation if the program will seek to become accredited. Assess the eligibility of the proposed program for accreditation. NOT APPLICABLE
D. Campus and Location Offering – indicate on which campus(es) and at which location(s) this program will be offered (this includes the Online campus). This is an in‐person, Main Campus program IV. STUDENT LEARNING OUTCOMES AND ASSESSMENT A. STUDENT OUTCOMES ‐‐ describe what students should know, understand, and/or be able to do at the conclusion of this program of study. i. Effectively communicate research design, significance, impact, results and interpretation in the form of written research proposals and publications. ii. Effectively communicate scientific findings, significance and impact of research findings to general scientific audiences through oral presentation. iii. Design, conduct, analyze and interpret original research on a significant biological problem in cell biology, medical biophysics, immunobiology, infection, or disease. iv. Demonstrate depth and breadth of scientific knowledge and concepts in his/her specific field and to the more general foundations of biological research. Demonstrate integrity and ethics in conducting and reporting scientific research B. STUDENT ASSESSMENT ‐‐ provide a plan for assessing intended student outcomes while the students are in the program and after they have completed the degree. Students will meet yearly with the Graduate Studies Committee to assess progress in the program. Students will receive written feedback on their progress, and suggestions and plans for improvement in meeting the program goals. For follow‐up with program graduates, a survey of graduates will be conducted every 5 years. This survey will track the employment history of program graduates. V. STATE'S NEED FOR THE PROGRAM A. HOW DOES THIS PROGRAM FULFILL THE NEEDS OF THE STATE OF ARIZONA AND THE REGION? ‐‐ INCLUDE AN EXPLANATION OF THE PROCESS OR SOURCE FOR ARRIVING AT ALL NUMBERS USED IN THIS SECTION 1. IS THERE SUFFICIENT STUDENT DEMAND FOR THE PROGRAM?
There is a demand for this program, attested by the fact that both programs that will be effectively merged within the new program have a consistent, demonstrated student demand. 2. What is the anticipated student enrollment for this program? (Please utilize the following tabular format). Estimates provided below are based on historical averages for students admitted each year into the IMB and CMM Programs. Each program admits an average of approximately 3 students/year. 5‐YEAR PROJECTED ANNUAL ENROLLMENT
1st Year 2nd Year 3rd Year 4th Year 5th Year
Number of Majors 6 12 18 24 30 3. What is the local, regional and national need for this program? Provide market analysis data or other tangible evidence of the need for and interest in this program This might include results from surveys of current students, alumni, and/or employers or reference to student enrollments in similar programs in the state or region. Include an assessment of the employment opportunities for graduates of the program during the next three years. The consistent matriculation of students into the IMB and CMM doctoral programs over 20+ years demonstrates a clear and sustained market for the training that will be provided by the Molecular Medicine Program. Employment opportunities for graduates remain strong; recent graduates of the IMB and CMM programs have a very high rate of placement in a variety of careers within biomedicine, including academic and government research, the biotechnology industry, and STEM education. 4. Beginning with the first year in which degrees will be awarded, what is the anticipated number of degrees that will be awarded each year for the first five years? (Please utilize the following tabular format). This proposal is for a PhD program, so the first students to enter the program will not graduate until 4‐5 years after program entry. PROJECTED DEGREES AWARDED ANNUALLY
Number of Degrees 0 0 0 2 5 IV. APPROPRIATENESS FOR THE UNIVERSITY ‐‐ Explain how the proposed program is consistent with the University mission and strategic direction statements of the university and why the university is the most appropriate location within the Arizona University System for the program. Please explain how this proposed program is consistent with the College strategic plan. The University of Arizona and the College of Medicine is an ideal home for this program. According to the University of Arizona Strategic Plan, the University’s mission is: “To improve the prospects and enrich the lives of the people of Arizona and the world through education, research, creative expression, and community and business partners.” The strategic plan for the College of Medicine (http://medicine.arizona.edu/about‐ college/strategic‐planning) is closely aligned with that of the University and includes a “major emphasis on expanding its biomedical research enterprise, as well as increasing its diversity and enhancing its partnerships and collaborations, among other efforts. The plan aims to create an academic health center that better serves the state of Arizona and its people—and, in so doing, emerge as one of the nation’s premier academic health centers.” The Molecule Medicine PhD Program will align well with these goals, preparing workforce‐ready students for Arizona and beyond. The efforts of trainees would support the goals of increasing research funding in the College. Based on the track record of students from the CMM and IMB programs, there is every reason to believe that students in Molecular Medicine will have a substantial positive impact on the University, the state workforce, and at the national level as they pursue careers in the biomedical sciences. Furthermore, the Molecular Medicine Program would continue the efforts of the IMB and CMM Programs to increase student and faculty diversity. V. EXISTING PROGRAMS WITHIN THE ARIZONA UNIVERSITY SYSTEM A. Arizona University System ‐‐ List all programs with the same CIP code definition at the same academic level (Bachelor's, Master's, Doctoral) currently offered in the Arizona University System. (Please utilize the following tabular format). CIP PROGRAM LOCATION PROGRAM ACCREDITATION?
CODE1 University & Site YES/NO 1 26.1401 Cellular and Molecular Medicine University of Arizona Main Campus YES 2 Curricular Affairs (and the Graduate College for graduate programs) will determine if you are required to complete a comparison chart to discuss the ways in which the proposed program differs from University of Arizona programs. The only existing programs in the Arizona University System with the same CIP code are the Cellular and Molecular Medicine (CMM) PhD and MS Programs at UA. This proposed Molecular Medicine PhD Program will supplant/replace the CMM PhD Program. The CMM MS Program will not be affected and will remain as its own Program. VI. EXPECTED FACULTY AND RESOURCE REQUIREMENTS A. FACULTY 1. Current Faculty ‐‐ List the name, rank, highest degree, primary department and estimate of the level of involvement of all current faculty members who will participate in the program. If proposed program is at the graduate level, also list the number of master's theses and doctoral dissertations each of these faculty members have directed to completion. Attach a brief vita for each faculty member listed. The attached spreadsheet contains a list of faculty that will participate in the Molecular Medicine Program. NOTE: All of the faculty listed already participate in the IMB and/or CMM PhD programs. Thus, they have been vetted and approved for those existing programs and no additional effort will be needed from these faculty for the Molecular Medicine Program. 2. Additional Faculty ‐‐ Describe the additional faculty needed during the next three years for the initiation of the program and list the anticipated schedule for addition of these faculty members. NONE
3. Current Student and Faculty FTEs ‐‐ Give the present numbers of Student FTE (identify number by graduate and undergraduate students) and Faculty FTE in the department or unit in which the program will be offered. Immunobiology Department: Faculty: 20 Students: 12 PhD Cellular and Molecular Medicine Department: Faculty: 33 Students: 16 PhD; 42 Master’s 4. Projected Student and Faculty FTEs ‐‐ Give the proposed numbers of Student FTE and Faculty FTE for the next three years in the department or unit in which the program will be offered. B. LIBRARY 1. Acquisitions Needed ‐‐ Describe additional library acquisitions needed during the next three years for the successful initiation of the program. No additional resources needed. C. PHYSICAL FACILITIES AND EQUIPMENT 1. Existing Physical Facilities ‐‐ Assess the adequacy of the existing physical facilities and equipment available to the proposed program. Include special classrooms, laboratories, physical equipment, computer facilities, etc.
1st Year 2nd Year 3rd Year
Students 69 69 69
Faculty 53 53 53
Existing facilities for this program are adequate. 2. Additional Facilities Required or Anticipated ‐‐ Describe physical facilities and equipment that will be required or are anticipated during the next three years for the proposed program. No additional facilities will be required. D. OTHER SUPPORT 1. Other Support Currently Available ‐‐ Include support staff, university and non‐university assistance. Two program coordinators provide primary support for students and faculty regarding graduate training. Other department staff support student financial and other affairs as needed. 2. Other Support Needed, Next Three Years ‐‐ List additional staff needed and other assistance needed for the next three years. No additional support need over the next three years. VII. FINANCING A. SUPPORTING FUNDS FROM OUTSIDE SOURCES ‐‐List. None B. BUDGET PROJECTIONS FORM ‐‐ Complete the budget projections form describing the current departmental budget and estimating additional costs for the first three years of operation for the proposed program. Please note that these costs for each year are incremental costs, not cumulative costs. Include in this budget the anticipated costs for support for instruction, administration of the program, graduate students, marketing, the support discussed in Section VI‐D.2, and any other costs that will be needed. See attached budget projection.
BUDGET PROJECTION FORM FOR ACADEMIC PROGRAMS Name of program: Molecular Medicine
Note that now new funds are required to implement this program as is represents a merger between two existing, supported programs.
The assumptions for the budget are as follows:
Faculty
28 primary mentors of PhD students
10% faculty effort in training and advising each student
AAMC 2015 Basic Science Faculty Compensation used in the discipline of “Molecular and Cellular Biology”. The average compensation of all ranks at the median percentile is $125,000
Base budget includes ERE at 34.7%
Other Personnel
Two program coordinators at 25% effort, averaging annualized fiscal salary of $58,000 at 34.7% ERE Two other department staff at 5% effort, averaging annualized fiscal salary of $65,000 at 34.7% ERE
Graduate Assistantships
GRA’s receive $25,000 stipend plus 31.7% ERE funded mostly with federal funds.
Operations (materials, supplies, phones, etc.)
General office and related supplies estimated to be $10,000
EXPENDITURE ITEMS INITIAL BASE
BUDGET
ANNUAL INCREMENTAL COSTS
Continuing Expenditures 1st Year 2nd Year 3rd Year
20_16_ - 20_17_ 20_17_ - 20_18_ 20_18_ - 20 _19_ Faculty State ___471,450_______ ______0_________ _______0________ Local _____0__________ ______0_________ _______0________ Other Personnel State _____47,820______ ______0_________ _______0________ Local _______0________ ______0_________ _______0________ Graduate Assistantships State ____921,900______ ______0_________ _______0________ Local _______________ _______________ _______________ Operations (materials, supplies, phones,
State ____10,000_______ ______0_________ _______0________ Local _______________ _______________ _______________ Other Items (Attach description)
State _______________ _______________ _______________ Local _______________ _______________ _______________
Construction or Renovation State _______________ _______________ _______________ Local _______________ _______________ _______________ Start-up Equipment State _______________ _______________ _______________ Local _______________ _______________ _______________ Replacement Equipment State _______________ _______________ _______________ Local _______________ _______________ _______________ Library Resources State _______________ _______________ _______________ Local _______________ _______________ _______________ Other Items (Attach description)
State _______________ _______________ _______________ Local _______________ _______________ _______________ TOTALS (Incremental) _______________ _______________ _______________ State-Reallocated Funds _______________ _______________ _______________ New Funds ______0_________ ______0_________ _______0________ Local Funds GRAND TOTALS $1,451,170 $0 $0
Name Home Title Department UA Title Highest Education Level Description Instructor Research Mentor Dissertation Committee Member
Ahmad, Nafees Immunobiology Professor J‐Doctorate (Academic) X
Campos, Samuel Immunobiology Assistant Professor J‐Doctorate (Academic) X X X
Doyle, Krisitan Immunobiology Assistant Professor L‐Post‐Doctorate X X X
Frelinger, Jeffrey Immunobiology Professor L‐Post‐Doctorate X X X
Friedman, Richard Immunobiology Professor L‐Post‐Doctorate X
Goodrum, Felicia Immunobiology Associate Professor J‐Doctorate (Academic) X X X
Harris, David Immunobiology Professor J‐Doctorate (Academic) X
Koshy, Anita Immunobiology Assistant Professor K‐Doctorate (Professional) X X X
Kuhns, Mike Immunobiology Assistant Professor L‐Post‐Doctorate X X X
Nikolich‐Zugich, Janko Immunobiology Professor and Dept. Head K‐Doctorate (Professional) X X X
Purdy, John Immunobiology Assistant Professor L‐Post‐Doctorate X X X
Schenten, Dominik Immunobiology Assistant Professor L‐Post‐Doctorate X X X
Smithey, Megan Immunobiology Research Assistant Professor L‐Post‐Doctorate X X X
So, Magdalene Immunobiology Professor J‐Doctorate (Academic) X X X
Wu, Hsin‐Jung Joyce Immunobiology Assistant Professor K‐Doctorate (Professional) X X X
Colson,Brett Cellular & Molecular Medicine Assistant Professor L‐Post‐Doctorate X X X
Cress,Anne E Cellular & Molecular Medicine Deputy Dean, Research Affairs J‐Doctorate (Academic) X X X
Doetschman,Thomas C Cellular & Molecular Medicine Professor J‐Doctorate (Academic) X X X
Elliott,David A Cellular & Molecular Medicine Assistant Professor (Educator Scholar Track) J‐Doctorate (Academic) X X
Ellis,Nathan Cellular & Molecular Medicine Associate Professor J‐Doctorate (Academic) X X X
Gordon,Herman Cellular & Molecular Medicine Associate Professor J‐Doctorate (Academic) X
Granzier,Hendrikus L Cellular & Molecular Medicine Professor J‐Doctorate (Academic) X X X
Gregorio,Carol C Cellular & Molecular Medicine Department Head J‐Doctorate (Academic) X X X
Harris,Samantha Cellular & Molecular Medicine Associate Professor J‐Doctorate (Academic) X X X
Ignatenko,Natalia Cellular & Molecular Medicine Associate Professor (Research Scholar Track) J‐Doctorate (Academic) X X X
Krieg,Paul A Cellular & Molecular Medicine Professor J‐Doctorate (Academic) X X
Lantz,Robert C Cellular & Molecular Medicine Professor J‐Doctorate (Academic) X X X
Lybarger,Lonnie P Cellular & Molecular Medicine Associate Professor J‐Doctorate (Academic) X X X
Maggert,Keith Cellular & Molecular Medicine Associate Professor L‐Post‐Doctorate X X X
Martinez,Jesse D Cellular & Molecular Medicine Professor J‐Doctorate (Academic) X X X
Mouneimne,Ghassan Cellular & Molecular Medicine Assistant Professor L‐Post‐Doctorate X X X
Ottenheijm,Coen A C Cellular & Molecular Medicine Associate Professor (Research Scholar Track) J‐Doctorate (Academic) X X X Pappas,Christopher T Cellular & Molecular Medicine Research Assistant Professor J‐Doctorate (Academic) X X Pivniouk,Vadim I Cellular & Molecular Medicine Associate Professor (Research Scholar Track) J‐Doctorate (Academic) X X
Rogers,Gregory C Cellular & Molecular Medicine Associate Professor J‐Doctorate (Academic) X X X
Runyan,Raymond B Cellular & Molecular Medicine Professor J‐Doctorate (Academic) X X X
Song,Jin Cellular & Molecular Medicine Research Assistant Professor L‐Post‐Doctorate X X
Vercelli,Donata Cellular & Molecular Medicine Professor K‐Doctorate (Professional) X X X
Warfel,Noel Andrew Cellular & Molecular Medicine Research Assistant Professor J‐Doctorate (Academic) X X X
Wilson,Jean M Cellular & Molecular Medicine Professor J‐Doctorate (Academic) X X X
Kiela,Pawel R Pediatrics Associate Professor J‐Doctorate (Academic) X X X
Vedantam, Gayatri Animal and Comparative Biomedical Sciences Associate Professor J‐Doctorate (Academic) X X X
Mcdermott,Kimberly M Medicine Assistant Professor J‐Doctorate (Academic) X X X
Tardiff,Jil C Medicine Professor K‐Doctorate (Professional) X X X
Knox, Kenneth S Medicine Professor K‐Doctorate (Professional) X X
Fares,Hanna F Molecular and Cellular Biology Professor J‐Doctorate (Academic) X X X
Zarnescu,Daniela C Molecular and Cellular Biology Associate Professor J‐Doctorate (Academic) X X X
Restifo,Linda L Neurology Professor J‐Doctorate (Academic) X X X
Konhilas,John P Physiology Associate Professor J‐Doctorate (Academic) X X X
Heimark,Ronald L Surgery Professor J‐Doctorate (Academic) X X X
Khalpey,Zain I Surgery Associate Professor J‐Doctorate (Academic) X X